Works matching IS 01433334 AND DT 2011 AND VI 32 AND IP 2


Results: 18
    1
    2
    3
    4
    5
    6

    GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.

    Published in:
    Carcinogenesis, 2011, v. 32, n. 2, p. 182, doi. 10.1093/carcin/bgq223
    By:
    • Moore, L.E.;
    • Baris, D.R.;
    • Figueroa, J.D.;
    • Garcia-Closas, M.;
    • Karagas, M.R.;
    • Schwenn, M.R.;
    • Johnson, A.T.;
    • Lubin, J.H.;
    • Hein, D.W.;
    • Dagnall, C.L.;
    • Colt, J.S.;
    • Kida, M.;
    • Jones, M.A.;
    • Schned, A.R.;
    • Cherala, S.S.;
    • Chanock, S.J.;
    • Cantor, K.P.;
    • Silverman, D.T.;
    • Rothman, N.
    Publication type:
    Article
    7
    8
    9
    10

    Frontmatter.

    Published in:
    Carcinogenesis, 2011, v. 32, n. 2, p. NP, doi. 10.1093/carcin/bgr013
    Publication type:
    Article
    11
    12
    13

    Backmatter.

    Published in:
    Carcinogenesis, 2011, v. 32, n. 2, p. NP, doi. 10.1093/carcin/bgr012
    Publication type:
    Article
    14
    15
    16
    17
    18

    Chemokine receptor CXCR3 promotes growth of glioma.

    Published in:
    Carcinogenesis, 2011, v. 32, n. 2, p. 129, doi. 10.1093/carcin/bgq224
    By:
    • Liu, Che;
    • Luo, Defang;
    • Reynolds, Brent A.;
    • Meher, Geeta;
    • Katritzky, Alan R.;
    • Lu, Bao;
    • Gerard, Craig J.;
    • Bhadha, Cyrus P.;
    • Harrison, Jeffrey K.
    Publication type:
    Article